Karachi, Haleon Pakistan Limited (HALEON), continuing its journey in the pharmaceutical sector since its 2017 listing, reported no dividends for the recent years, despite an earnings per share (EPS) of Rs. 2.78* for the early months of 2024. The company's trading rate was Rs. 183.40, with a high of Rs. 225, indicating its commitment to growth and operational excellence. Haleon Pakistan, with a market lot size of 100 units, remains focused on delivering healthcare solutions and enhancing shareholder value.